Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study

Table 1 Baseline characteristics of all patients

Characteristics n (1,515)	CHD group n (256)	no CHD group n (1,259)	p value
Age, yrs	72.7 ± 10.0	66.4 ± 13.4	<0.001
Female, %	22.3	34.4	<0.001
Diabetes mellitus, %	64.8	48.2	<0.001
BMI, kg/m²	23.0 ± 3.5	23.6 ± 4.5	0.062
SBP, mmHg	143 ± 26	153 ± 26	<0.001
DBP, mmHg	72 ± 14	78 ± 15	<0.001
eGFR, ml/min/1.73 m²	6.4 ± 3.1	5.2 ± 1.9	<0.001
Creatinine, mg/dL	7.84 ± 2.51	9.21 ± 3.30	<0.001
BUN, mg/dL	88.3 ± 28.9	92.4 ± 30.7	0.048
Hemoglobin, g/dL	9.4 ± 1.4	9.4 ± 1.6	0.909
Albumin, g/dL	3.15 ± 0.58	3.21 ± 0.60	0.111
Uric acid, mg/dL	8.8 ± 2.7	8.8 ± 2.3	0.894
Potassium, mEq/L	4.5 ± 0.8	4.6 ± 0.8	0.271
Adjusted calcium, mg/dL	8.8 ± 0.9	8.6 ± 1.1	0.023
Phosphorus, mg/dL	5.8 ± 1.5	6.5 ± 1.9	<0.001
LDL-cholesterol, mg/dL	83 ± 32	91 ± 35	0.002
HDL-cholesterol, mg/dL	41 ± 14	45 ± 17	<0.001
Triglyceride, mg/dL	125 ± 95	125 ± 64	0.959
CRP, mg/dL	2.0 ± 3.3	1.8 ± 4.3	0.532
Use of ARBs or ACEIs, %	61.7	60.1	0.674
Use of β-blockers, %	56.3	30.2	<0.001
Use of anti-platelet agents, %	73.8	21.4	<0.001
Use of warfarin, %	12.9	5.8	<0.001
Use of loop diuretics, %	77.3	63.3	<0.001
Use of statins, %	66.4	34.8	<0.001
Use of ESAs, %	84.8	86.1	0.621

Mean ± Standard deviation
CHD coronary heart disease, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, BUN blood urea nitrogen, LDL low density lipoprotein, HDL high density lipoprotein, CRP C-reactive protein, ARBs angiotensin receptor blockers, ESAs erythropoiesis stimulating agents

ISSN: 1471-2369